NSEOutcome of Board Meeting5h ago · 25 Sept 2026, 01:29 pm

Outcome of Board Meeting

Molbio Diagnostics Limited · MOLBIO

✦ AI Summary

Molbio Diagnostics Limited has informed the Exchange regarding the re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Molbio Diagnostics Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026 for re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27.

Attachments (1)

📄

MOLBIO_25092026132851_Intimation_Cost_auditor_Signed.pdf

pdf

Download →
View document text
Date: September 25, 2026 BSE Limited (BSE’) National Stock Exchange of India Ltd Listing Department Exchange Plaza, Corporate Relationship Department B a n d r a - Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai 400 051 2nd Floor, Dalal Street, Symbol: MOLBIO Mumbai – 400 001 BSE Script Code: 544866 Subject: Intimation of re-appointment of Cost Auditor of the Company pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Dear Sir/Ma’am, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors, at their meeting held on today, September 25, 2026, has inter-alia considered and approved the following: 1. Re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants (Firm Reg. No: 000296), a Peer-reviewed firm as the Cost Auditors of the Company to conduct audit of the cost accounts for the Financial Year 2026-27. The disclosure as required under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as amended from time to time are enclosed here as “Annexure-A” The Board Meeting commenced at 11.26 A.M and concluded at 11.35 A.M. The above intimation is also available on the Company’s website at www.molbiodiagnostics.com in compliance with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We request you to kindly take the same on your record. Thanking You. Yours Faithfully, For Molbio Diagnostics Limited Darshan Raghunath Karekar Company Secretary & Compliance Officer M.No: F13569 Place: Verna-Goa Annexure – A Disclosure as required pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026: Sr. Particulars Details 1 Reason for change viz Re-appointment of M/s. Kamalakara & Co, appointment, resignation; (FRN:000296), Cost accountant, as the cost removal-death-or-otherwise: auditors of the Company for the financial year 2026-27. 2 Date of Date of Re-appointment: September 25, 2026. appointment/cessation—(as— Term of Re-appointment: For the financial year applicable) & term of 2026-27. appointment 3 Brief profile (in case of M/s. K.S. Kamalakara & Co. is a prominent and appointment/ re-appointment). professionally managed firm of Cost Accountants (Firm Registration No. 000296) based in Bengaluru, India. The firm specializes in GST, Cost Accounting, Financial Accounting, Import-Export Policy, Customs, Export Benefit Claims, FEMA compliances, litigation support, and preparation of project reports for financing and other business requirements. The firm is led by its founding partner, CMA K. S. Kamalakara (M.Com., FCMA), a Fellow Cost Accountant with over two decades of experience and expertise in cost records, cost audits, indirect taxation, and corporate litigation matters. 4 Disclosure of relationships NA between directors (in case of appointment of a director)